Key Principles and Recommended Regimens for First-line Antiretroviral Therapy

  • Author: Paul E. Sax, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 9/10/19 (What's New)

Summary

    Efavirenz-Based Initial Therapy
    • There are currently 5 NNRTIs approved for first-line use in HIV-infected patients
    • Efavirenz, the standard-of-care first-line NNRTI for many years, is no longer included in recommended first-line regimens in guidelines, but remains a component of alternative first-line regimens[IAS-USA ART; DHHS ART; EACS ART]
    • Efavirenz-based first-line therapy is not optimal for:
      Rilpivirine-Based Initial Therapy
        Doravirine-Based Initial Therapy
          Considerations for Choosing a First-line NNRTI

          Action required